.svg?rev=0123a45359b34a45b72f615f84c63d11&hash=D9D267D4F8A003D6A105C987E125D147){kind=logo}
Health & Life Sciences
Overview
As a stakeholder in the health and life sciences sector, you work every day to improve human health and enhance patient care. Our national health and life sciences team partners with industry leaders like you — biotech innovators, pharmaceutical and medical device manufacturers, health systems, investors, and digital health pioneers — to help you thrive in a landscape defined by rapid change and increasingly complex regulatory demands.
Our professionals have extensive practical experience to help you navigate the sector’s most critical business and legal challenges. We advise on transformative mergers and acquisitions, strategic investments, and capital deployment, ensuring your transactions are efficient and positioned for long-term growth and innovation. Our team handles high-stakes litigation and government investigations, providing sophisticated advocacy and clear strategic guidance when challenges arise.
We support you throughout the business life cycle — structuring and negotiating technology transactions, licensing, and collaborations; guiding you through complex regulatory requirements at all stages of the product lifecycle; and implementing proactive risk management and compliance solutions. Our capabilities also encompass employee benefits and executive compensation, privacy and data security, outsourcing, intellectual property, and public policy strategy, helping you seize opportunities and mitigate risk in every aspect of your operations.
Our team includes former in-house counsel to major health systems and global life sciences companies, as well as former FDA, other federal agency and Capitol Hill health policy advisors, and former Department of Justice attorneys. With this blend of industry insight and legal acumen, we deliver practical, business-minded solutions tailored to your most complex challenges so you can continue advancing your mission and achieving your strategic objectives in a rapidly evolving sector.
Health & Life Sciences Segments
Insights & Events
Latest
Federal Court Addresses Trade-Secret Protection When Startups Pitch to Venture Capital Investors
Richard Scheff Receives American Caribbean Maritime Foundation’s Anchor Award for Service to Maritime Legal Community
SBA Proposes Sweeping Overhaul of Small Business Size Standards for 338 Industry Groups
DC Circuit Upholds EPA's PFAS Hazardous Substance Designations under CERCLA: What In-House Counsel Need to Know
Faegre Drinker Welcomes Veteran Trial Lawyer Chad Hummel in Los Angeles
SBA Finalizes Rule Removing Rebuttable Presumption of Social Disadvantage for Individually Owned 8(a) Firms
AI Briefing: Frontier AI Models Gone Rogue, DeepMind CEO Calls for Oversight Body, and NY Pauses Data Center Permits
Tariffs, Trade Policy, and Supply Chains Under Pressure: Critical Considerations for Life Sciences Companies Operating in High-Stakes International Markets
Florida IP Litigation & Regional Innovation
From Refunds to Risk — Understanding the IEEPA Class Action & B2B Claims Landscape - Webinar
Insights
Federal Court Addresses Trade-Secret Protection When Startups Pitch to Venture Capital Investors
SBA Proposes Sweeping Overhaul of Small Business Size Standards for 338 Industry Groups
DC Circuit Upholds EPA's PFAS Hazardous Substance Designations under CERCLA: What In-House Counsel Need to Know
SBA Finalizes Rule Removing Rebuttable Presumption of Social Disadvantage for Individually Owned 8(a) Firms
AI Briefing: Frontier AI Models Gone Rogue, DeepMind CEO Calls for Oversight Body, and NY Pauses Data Center Permits
Nick Nastasi Comments on 340B Legislative Outlook With Healthcare Financial Management Association
Mollie Sitkowski Discusses CBP’s Guidance on Section 232 Pharma Tariffs in International Trade Today
Mollie Sitkowski Comments on Pharmaceutical Tariff Developments in Endpoints News
Unlocking the Right to Repair: The Expanding Compliance Landscape
Noncompete Laws Show States Focusing On Bans, Healthcare
Events
Past Events
Tariffs, Trade Policy, and Supply Chains Under Pressure: Critical Considerations for Life Sciences Companies Operating in High-Stakes International Markets
Florida IP Litigation & Regional Innovation
Aligning FDA Regulatory Support and Advocacy
Making Waves: Advance Legal Topics in Other Transaction Agreements
From Refunds to Risk — Understanding the IEEPA Class Action & B2B Claims Landscape - Webinar
News
Richard Scheff Receives American Caribbean Maritime Foundation’s Anchor Award for Service to Maritime Legal Community
Faegre Drinker Welcomes Veteran Trial Lawyer Chad Hummel in Los Angeles
Faegre Drinker and Christina Huang Recognized as Top IPR US Law Firm and Lawyer by IPR Daily
Former 3M Assistant General Counsel Norman Pentelovitch Joins Faegre Drinker Litigation Group
Minnesota Lawyer Recognizes Richard Bennett and Kelly Fermoyle as 2026 ‘Up & Coming Attorneys’
The Legal 500 United States 2026 Guide Recognizes Faegre Drinker Practices and Attorneys
1851 Franchise Spotlights Brian Schnell in 2026 ‘Top Franchise Lawyers You Should Know’ Series
Faegre Drinker Welcomes Former Elevance Health Transactions Counsel Greg Gentry to Corporate Group
Trevor Belden and James Strickland Named Indiana Lawyer ‘Leadership in Law’ Honorees
Eli Isaacs Honored With M&A Advisor’s 2026 ‘Emerging Leaders’ Award
Related Legal Services
Experience
Our Experience
Teva Pharmaceutical Completes Agreement to Acquire Emalex Biosciences
Surmodics Inc. Agrees to $627M Acquisition by GTCR
Mineralys Therapeutics, Inc. Enters into $100M ATM Equity Offering Sales Agreement
Cook Medical Litigates National MDL Involving IVC Filter
Elevance Health Enters Strategic Partnership to Advance Primary Care Delivery
Faegre Drinker Represents Miromatrix Medical Inc. in Sale of Company to United Therapeutics Corporation
Meet The Team
Meet The Full Health & Life Sciences Team
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Tricia A. Beckmann
Principal - Faegre Drinker Consulting -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Jillian K. Brady
Senior Manager - Science, Regulation, & Policy -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Kacey B. Dugan
Director - Policy & Regulatory Affairs -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Terry L. Frangiosa
Principal - Faegre Drinker Consulting -
Timothy R. Franson, M.D.
Principal - Faegre Drinker Consulting -
-
-
-
-
-
-
-
-
Mary Susan Gerber
Intellectual Property Attorney -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Megan S. Herber
Principal - Faegre Drinker Consulting -
-
-
-
-
-
-
-
-
-
Andrew G. Humphrey
Partner and Chair Emeritus -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Andrew C. Kassner
Partner and Chair Emeritus -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nicholas P. Manetto
Principal - Faegre Drinker Consulting -
-
-
Rebekah A. Marfo
Manager - Data Privacy & Digital Media Compliance -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Ilse Peterson, MPH
Director - Research & Strategy -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Fatou Hann Sarr
Manager - Research & Policy -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dasha Ternavska
Senior Product Liability & Mass Torts Attorney -
-
-
-
-
-
-
-
-
-
-
-
Elliot D. Vice
Director - Health Policy & Government Relations -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
David R. Zook
Chair - Faegre Drinker Consulting